Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers

Clinical trial NCT01901198 · COMPLETED

Trial details

NCT number: NCT01901198
Sponsor: Beijing Bio-Fortune Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2013-04-01
Primary completion: 2013-09-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.